Front Range Biosciences Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 45

Employees

  • Latest Deal Type
  • Series B2

  • Latest Deal Amount
  • $46M

  • Investors
  • 29

Front Range Biosciences General Information

Description

Operator of an agricultural biotech company intended to provide technology for the breeding and production of new plant varieties and seeds of valuable crops. The company offers rooted cuttings and pre-finished plants of hemp varieties, feminized hemp seeds, and nursery services, enabling cannabis cultivators to improve their yields, reduce disease and create novel strains.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Consumer Non-Durables
Other Industries
Other Agriculture
Cultivation
Corporate Office
  • 6400 Lookout Road
  • Suite 200
  • Boulder, CO 80301
  • United States
+1 (720) 000-0000

Front Range Biosciences Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Front Range Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series B2) 15-Jul-2021 $46M 00000 00000 Completed Generating Revenue
9. Later Stage VC (Series B1) 0000 000.00 00000 Completed Generating Revenue
8. Later Stage VC (Series A1) 31-Dec-2020 000.00 000.00 0000 Completed Generating Revenue
7. Later Stage VC 14-Feb-2020 000.00 000.00 000.00 Completed Generating Revenue
6. Angel (individual) 31-Dec-2019 000.00 Completed Generating Revenue
5. Angel (individual) 000.00 Completed Generating Revenue
4. Early Stage VC (Series A) 04-Oct-2018 000.00 000.00 000.00 Completed Generating Revenue
3. Angel (individual) 31-Dec-2017 0000 Completed Generating Revenue
2. Debt - General 09-Aug-2016 $30K Completed Generating Revenue
1. Accelerator/Incubator 25-Feb-2016 $30K $30K Completed Generating Revenue
To view Front Range Biosciences’s complete valuation and funding history, request access »

Front Range Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-2 00,000,000 00.000000 00.00 00.00 00 00.00 00.00
Series B-1 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A-1 10,839,396 $0.001000 $2.22 $2.22 1x $1.96 12.52%
Series A 11,339,396 $0.001000 $2.22 $2.22 1x $1.96 13.09%
To view Front Range Biosciences’s complete cap table history, request access »

Front Range Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an agricultural biotech company intended to provide technology for the breeding and production of new plant
Other Consumer Non-Durables
Boulder, CO
45 As of 2022
00000
0000 0000-00-00
00000000000 00000

00000

ip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
0000000000000
Santa Fe, NM
00 As of 0000
000.00
0000000000 0 000.00

00000

henderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepte
0000000000000
Richmond, Canada
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Front Range Biosciences Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Trait Biosciences Venture Capital-Backed Santa Fe, NM 00 000.00 0000000000 0 000.00
Segra Venture Capital-Backed Richmond, Canada 00 000.00 00000000000 000.00
Canndescent Venture Capital-Backed Santa Barbara, CA 00 0000 00000 00000 0000
Ilan Bio Pending Transaction (M&A) Givat Hen, Israel 000000000000
Meristem Angel-Backed Bracknell, United Kingdom 0000000000
You’re viewing 5 of 5 competitors. Get the full list »

Front Range Biosciences Patents

Front Range Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230357868-A1 Compositions and methods for obtaining plant cultivars with desired terpene profiles based on terpene synthase gene selection Pending 29-Dec-2021 0000000000
US-20220256799-A1 Cannabis plant named 'lpa004' Pending 17-Feb-2021 00000000
US-20230002779-A1 Characterization of plant cultivars based on terpene synthase gene profiles Inactive 29-Jun-2020 00000000
CA-3188481-A1 Characterization of cannabis cultivars based on terpene synthase gene profiles Pending 29-Jun-2020 00000000000
US-20210381039-A1 Methods and compositions for pathogen detection in plants Pending 29-May-2020 C12Q1/6853
To view Front Range Biosciences’s complete patent history, request access »

Front Range Biosciences Executive Team (11)

Name Title Board Seat Contact Info
Chris Driessen Chief Executive Officer
Julian Torrez Financial Controller
Christopher Zalewski Ph.D Co-Founder, Vice President of Operations & Director of Research, Plant Sciences
Reggie Gaudino Ph.D Chief Scientific Officer & Vice President of Research & Development
You’re viewing 4 of 11 executive team members. Get the full list »

Front Range Biosciences Board Members (7)

Name Representing Role Since
Ephraim Lindenbaum Advance Ventures Board Observer 000 0000
Marc Riiska Tuatara Capital Board Member 000 0000
Pete Karabas Key Investment Partners Board of Director, Observer 000 0000
Young Yeo Tuatara Capital Board Member 000 0000
You’re viewing 4 of 7 board members. Get the full list »

Front Range Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Front Range Biosciences Investors (29)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advance Ventures Venture Capital Minority 000 0000 000000 0
Key Investment Partners Venture Capital Minority 000 0000 000000 0
Tuatara Capital Growth/Expansion Minority 000 0000 000000 0
AFI Capital Partners Growth/Expansion Minority 000 0000 000000 0
Alicia Syrett Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 29 investors. Get the full list »

Front Range Biosciences Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Steep Hill (Genomics Research & Development Team) 15-Aug-2019 0000000000 Other Pharmaceuticals and Biotechnology 00000000
To view Front Range Biosciences’s complete acquisitions history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »